What Next for Hepatitis B therapy? an Interview With Jean-Michel Pawlotsky

Biography

In this exclusive interview, Jean-Michel Pawlotsky discusses present-day and developing therapies for treating hepatitis B viral infection, with a view for future directions and predictions for this currently incurable disease. This interview was conducted by Ellen Colvin, Editor of Future Virology.

Dr Jean-Michel Pawlotsky is a Professor of Medicine at the University of Paris-Est, France. He is the Director of the National Reference Center for Viral hepatitis B, C and D and of the Department of Virology at the Henri Mondor University Hospital in Créteil, France, and the Director of Research Team “Viruses-Hepatology-Cancers” at the Mondor Institute of Biomedical Research (INSERM U955). Dr Pawlotsky earned his medical degree in Hepatology and Gastroenterology in 1992. Furthermore, he earned a thesis in molecular virology from the University of Paris, France, and is a graduate in virology and microbiology. Dr Pawlotsky acted as the Secretary General of the European Association for the Study of the Liver (EASL) between 2005 and 2009. He is a member of the Strategic Committee of the National Agency for Research on AIDS and Viral Hepatitis (ANRS). Dr Pawlotsky’s noted career contributions include 500 published articles and book chapters and over 650 invited lectures at international meetings.

Financial and competing interests disclosure

The author acted as an advisor for Abbott, Abbvie, Gilead, GSK, Merck and Siemens Healthcare. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Disclaimer

The opinions expressed in this interview are those of JM Pawlotsky and do not necessarily reflect the views of Future Medicine Ltd.